RESEARCH-USE BIOSIMILAR ANTIBODY
Emapalumab
Monoclonal antibody · IgG1
Emapalumab (NI-0501) is a human monoclonal IgG1 antibody that noncompetitively inhibits IFN-γ. Emapalumab binds with high affinity (Kd= 1.4 pM) to both free IFN-γ as well as IFN-γ bound to its receptor. Emapalumab can be used in research of hemophagocytic lymphohistiocytosis (HLH).
TARGETIFNγ
YMonoclonal antibody
CATALOGSC-BS-593
CATALOG NUMBERSC-BS-593
MOLECULAR WEIGHTApprox. 145.22 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Emapalumab (NI-0501) is a human monoclonal IgG1 antibody that noncompetitively inhibits IFN-γ. Emapalumab binds with high affinity (Kd= 1.4 pM) to both free IFN-γ as well as IFN-γ bound to its receptor. Emapalumab can be used in research of hemophagocytic lymphohistiocytosis (HLH).
Emapalumab is a recombinant research-use antibody directed against IFNγ.